19. February 2020 – 21. February 2020

19 – 21 February 2020

Wellcome Genome Campus, UK

The conference will explore and discuss various aspects of the non-specific effects of vaccines, including their impact on neonates and infants, how generalisable and durable these effects are, the implications for geriatric and veterinary medicine, and why non-specific effects should differ between sexes and across the lifespan.

For more information: Optimmunize_2019_A4_Poster

And: Conference website

Immunology seminar by Valentyn Oksenych: New factors required for lymphocyte development: in vivo models

On Monday, December 9th, Søren Degn will host a seminar given by Valentyn Oksenych, PhD,

group leader at Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

The title of this I&I International Seminar is:


New factors required for lymphocyte development: in vivo models


Venue: Merete Barker Auditorium, (Bldg. 1253-211 / Lake side lecture theatres)


Time: 10:00-11:00am



Development of B and T lymphocytes depends on the DNA breaks and repair events known as V(D)J recombination. There are two molecular pathways involved in the DNA repair during the lymphocyte development, non-homologous end joining (NHEJ) and DNA damage response (DDR). Recently, new accessory NHEJ factors PAXX and Mri were reported. Deficiency for PAXX or Mri, however, had no obvious effect on the lymphocyte development. Applying genetic models, we found that PAXX and Mri are functionally redundant with another NHEJ factor, XLF. Moreover, combined deficiency for XLF/PAXX and XLF/Mri results in dramatic, although distinct, phenotypes. In addition, we found that multiple factors from the DDR pathway are required for specific stages of B cell development.

PhD defence: Broadening the T cell response against hepatitis C virus by vaccination with peptides in cationic particles

Broadening the T cell response against hepatitis C
virus by vaccination with peptides in cationic
by Jonathan Filskov
Copenhagen Hepatitis C Program (CO-HEP)
Department of Infectious Diseases, Hvidovre Hospital
Department of Immunology and Microbiology, Faculty of Health
and Medical Sciences, University of Copenhagen
Department of Infectious Disease Immunology, Statens Serum Institut (SSI)
November 25, 2019 at 14:00
Auditorium 3+4, Hvidovre Hospital
Kettegård Allé 30, 2650 Hvidovre

For more info PhD defence invitation_Jonathan Filskov_Final.

IMMUNONET Basic science network day at Novo Nordisk Fonden

On the 12th of September, 2019 IMMUNONET will host a Basic science network day at Novo Nordisk
Fonden, Tuborg Havnevej 19, 2900 Hellerup.

The topic will be “New leads in Cancer Immunotherapy”. We will have a keynote speaker at 13:00.

Poster presentations will be in focus, we therefore call for young scientist in the field of immunooncology
to submit abstracts in the categories:

1. ‘New targets/new leads’
2. ‘Translational IO’
3. ‘Immunotechnologies’
4. ‘Biomarkers’

Abstracts will be selected for a short on‐site poster presentation of 4 minutes.

For more information, please click here: _Invitation network day.

Postdoc in Immunological Biotechnology at Dept. of Engineering, Faculty of Science and Technology, Aarhus University

Applications are invited for a Postdoctoral Fellow position in “Immunological Biotechnology” at the Department of Engineering, Section of Biotechnology and Chemical Engineering, Aarhus University Denmark.

The position is available from October 1st, 2019 or as soon as possible hereafter to the end of 2021.
Click here for more information and details on the application procedure.

Postdoc position in the Precision Vaccines Laboratory, Harvard Institutes of Medicine, Boston, USA

We seek a skilled and motivated post-doctoral scientist with background in Immunology (experience in T and B lymphocyte studies a plus), Vaccinology, and/or Systems Biology to lead a project on development of novel adjuvanted vaccines. We are funded by NIH/NIAID via an Adjuvant Discovery and Development Program contracts, a UO1 grant on adjuvant synergy and a U19 Human Immunology Project Consortium (HIPC) award to study systems vaccinology. Studies will employ in vitro modeling of human newborn, adult and elderly antigen-presenting cells, T and B lymphocytes, small molecule screens, medicinal chemistry, adjuvant formulation as well as in vivo animal and human studies and big data “OMIC” technologies, to identify and develop adjuvants that enhance immune responses of those at the extremes of age.

For more information: 06APRIL2019Post-DocPostingLevy-PrecisionVaccines